Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis. - Wikidata - awgldk - TriplyDB

Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.

Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q50590704

about

The Immune Landscape in Nonalcoholic Steatohepatitis.Natural killer cells in liver disease IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Natural killer group 2 member D, its ligands, and liver disease: good or bad?Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.What does irritable bowel syndrome share with non-alcoholic fatty liver disease?TRAIL-producing NK cells contribute to liver injury and related fibrogenesis in the context of GNMT deficiency.A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistance.Death receptor 5 signaling promotes hepatocyte lipoapoptosis Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice.Innate immunity in alcoholic liver disease.Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.Roles of liver innate immune cells in nonalcoholic fatty liver disease.Role of stress-induced NKG2D ligands in liver diseases.Immune cells and metabolic dysfunction.Targeting apoptosis in autoimmune hepatitis.MICA SNPs and the NKG2D system in virus-induced HCC.Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis.Evolving paradigm of treatment for autoimmune hepatitis.CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease.Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.New biomarkers for antenatal infection: MICA vs MICB gene expression in preterm babies.Natural killer cells take two tolls to destruct bile ducts.Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.Serum soluble major histocompatibility complex class I-related chain A/B expression in patients with alcoholic liver disease in Hainan Li community.Frequency and phenotype of human circulating and intrahepatic natural killer cell subsets is differentially regulated according to stage of chronic liver disease.Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non-alcoholic fatty liver disease.HLA DQB1 alleles are related with nonalcoholic fatty liver disease.Apoptosis and non-alcoholic fatty liver diseases.Circulating biomarkers in hepatocellular carcinoma Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy The Paradoxical Role of NKG2D in Cancer Immunity

P2860

Q26747323-ADA8D6CD-361C-4748-B3D3-88191198A7C2 Q27025451-C3F1E8E8-93A1-4B63-A0A2-687437C2E3C2 Q27025620-8196B19B-F33A-4B10-A67C-7FEEB628E20A Q30382395-63EA9E0A-413E-4973-9CCF-CCE6DFEB66F8 Q33563338-98B764EE-9E76-4AC1-A027-A4A96EA1928F Q33755829-1288D4ED-19FC-4114-99A5-A166F4B1BBE8 Q34872953-20E41DC8-629B-40FF-8C17-00F288423023 Q34983471-D15E2C10-C890-48F2-AE95-444D17EB3AE7 Q35027678-14B30DCF-D8EE-4219-82E4-CD1ED0106E2B Q35107291-214280C4-E0D0-487E-BB78-81B822860696 Q35355536-13BB4FA6-C6EB-4B87-8EF5-AD8D32A4433D Q35604362-5819B761-57B6-47E0-91FE-0B0340F3E33F Q35660292-6D7E6ED6-AC76-4246-A391-0E6496F4CE1B Q37174755-414D69D5-5A28-4873-A27A-863FFF608131 Q37300367-8BF80CC7-2DF7-4325-A8B4-46F4BF808EE5 Q37793003-5E6F4B93-6D2B-4AEC-B09F-858331AD5F49 Q37957971-079AF4FB-72C4-44EB-99BD-A8FB7072BA05 Q38161295-A9228AA5-8BA5-4706-A419-FC2E8212C575 Q38231217-BA29140C-10B7-47AE-8A78-BE9B374B966C Q38255751-39B5854A-A2AE-4F2D-A140-C7F1E0FAE019 Q38648556-977B44E4-9040-440F-9C78-99BD351A5147 Q38730872-B9696D75-2776-4E0E-91E1-6F0DD36D7B9F Q39709114-4FD9BB47-0C71-4808-A2D2-8E9CC94A7FCC Q41491276-7F5E9E27-A6C1-4A89-8238-8E99604E90A4 Q41602358-EA2F1B30-9B18-417D-8C5B-825D987E8787 Q41926263-26FC4480-0567-4F07-83C1-117F4FBFC3BD Q42536141-49F0A33A-16A0-4ADE-AFA3-F332687F0B9C Q42979699-D2C5A994-5EC7-4A6D-9485-59D09CA388FD Q43209848-016790F2-046F-4371-8C21-F0D8EAB0561F Q43704795-D1504192-5E62-4C96-8421-9CCAC1411114 Q44561660-DF5FA97B-EE3C-4A6E-885E-5D2E8A6B80EB Q49790075-344DA974-5333-401B-8B22-E8C1C24EEF22 Q50531945-7F33DD02-8E9B-4997-B8DA-067EE91836C3 Q54193741-D3D40C8F-088D-49CE-815F-7B917782409A Q55503094-00B6C7B1-5DA4-49D4-BAA1-658C7731D750 Q58282111-3447E9E5-8BC8-40AD-88A5-16BAB614F632 Q58764532-E82D31FA-2B88-40A4-95C6-4FD3BABC4BB5 Q58785685-FA71A32B-06E2-4A24-82C2-BA2EB5F47FDB

P2860

Major histocompatibility complex class I-related chains A and B (MIC A/B): a novel role in nonalcoholic steatohepatitis.

http://www.wikidata.org/entity/Q50590704

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Major histocompatibility compl ...... nonalcoholic steatohepatitis.

@en

Major histocompatibility complex class I-related chains A and B

@nl

type

label

Major histocompatibility compl ...... nonalcoholic steatohepatitis.

@en

Major histocompatibility complex class I-related chains A and B

@nl

prefLabel

Major histocompatibility compl ...... nonalcoholic steatohepatitis.

@en

Major histocompatibility complex class I-related chains A and B

@nl

P1433

Q50590704-12D50788-E8B3-474E-95DF-1F741BF5F18A

P1476

Q50590704-6BD6C8C8-D6A5-473D-8CF1-5E37E8C90EF4

P2093

Q50590704-12DFF828-001F-4BB0-86EB-C96A451BEE2B

Q50590704-318949A7-9CCE-4AE1-8D74-A568BC08EB82

Q50590704-571934D1-77C5-45D5-ABC8-AA178A2E904E

Q50590704-8CC80AED-3115-4F45-8692-80C7C31132AA

Q50590704-8EE04085-6A77-48E0-BE4E-DDCF10780522

Q50590704-B7DC4A02-CE36-48D3-B881-32571F46DD31

Q50590704-BA47CAF8-8007-4D9D-B9CD-C6E70565C3BC

Q50590704-C375785F-580F-451D-9232-65A223F518EE

Q50590704-C71D3DC8-8830-459F-A874-9FA52587027E

Q50590704-D7A4F87B-F334-4B3A-8FD3-8E02DD8E001C

P2860

Q50590704-058FABED-BF76-4B86-9115-FEFD08BE35E9

Q50590704-07CA396D-C1E6-420E-8C0D-0C82C183118B

Q50590704-10921EB6-8558-4EB7-A92D-22C3632C1241

Q50590704-1E2C8494-AC4B-4D8C-B7E8-D994B6570763

Q50590704-22731643-7B47-478E-ADCF-9B177079EFF5

Q50590704-2C2312E1-F03F-4F81-9C27-A6F1AF59C56D

Q50590704-376CDD2B-34CC-46B3-9E4A-0F65ED7EB6FF

Q50590704-43838E9C-DAA7-4075-BAA4-34339932C3D2

Q50590704-4B608292-AF78-4DF6-8D51-4E949248D7DD

Q50590704-54C86567-6E06-49E4-92B0-4F92D02A251D

P304

Q50590704-EB9DE0DE-CD65-4315-B9FE-3DEBBDACFD30

P31

Q50590704-0C84C146-B843-4D04-ACD6-0064AD90721C

P356

Q50590704-5D8B7B73-5CA3-47E5-AFD9-600984442865

P407

Q50590704-01EA4947-EAA3-4072-A676-1D2F095DB8BB

P433

Q50590704-65B4E775-D1CB-47C3-854B-9AB291BC3CB2

P478

Q50590704-C1B2A76C-EF5D-4124-B7E1-AC1DA8906AA7

P50

Q50590704-D2C06BA4-1C3E-4AC8-9159-A207001A03E1

P577

Q50590704-DDDBC967-9F64-4ED7-9148-8CC705942311

P5875

Q50590704-95B2D25E-E8D7-450A-8A89-CB9C13D26094

P698

Q50590704-F85631E8-5168-40DE-8306-9FB560304D5D

P921

Q50590704-42D84EF9-F636-47B2-ACE7-AB475B0F3215

P356

P1433

P1476

Major histocompatibility compl ...... nonalcoholic steatohepatitis.

@en

P2093

Ali Canbay

http://www.w3.org/2001/XMLSchema#string

Alisan Kahraman

http://www.w3.org/2001/XMLSchema#string

Christian D Fingas

http://www.w3.org/2001/XMLSchema#string

Guido Marquitan

http://www.w3.org/2001/XMLSchema#string

Hideo A Baba

http://www.w3.org/2001/XMLSchema#string

Inga Wedemeyer

http://www.w3.org/2001/XMLSchema#string

Martin Schlattjan

http://www.w3.org/2001/XMLSchema#string

Matthias Schlensak

http://www.w3.org/2001/XMLSchema#string

Peri Kocabayoglu

http://www.w3.org/2001/XMLSchema#string

Robert K Gieseler

http://www.w3.org/2001/XMLSchema#string

P2860

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

An activating immunoreceptor complex formed by NKG2D and DAP10

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA

Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Subacute liver failure in obese women.

P304

92-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23253

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40485194

http://www.w3.org/2001/XMLSchema#string

P698

19998387

http://www.w3.org/2001/XMLSchema#string

P921

Steatohepatitis